General MedicationsORALGeneric

METHYLPHENIDATE

Standard Dose

25.9MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview METHYLPHENIDATE is listed in Drugs@FDA under application 210924 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient METHYLPHENIDATE Form and strength TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - 25.9MG Sponsor ACTAVIS ELIZABETH Submission history Latest submission status date: 2020-06-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview METHYLPHENIDATE is listed in Drugs@FDA under application 210924 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient METHYLPHENIDATE Form and strength TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - 25.9MG Sponsor ACTAVIS ELIZABETH Submission history Latest submission status date: 2020-06-19 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.